4D Molecular Therapeutics Inc

$9.66
Market Cap 493.16M
ROE -36.8%
Gross Margin 100.0%
Debt/Equity 0.0
Current Ratio 9.3
Revenue QoQ 21664.3%
EPS QoQ 0.2%
F-Score 1

About

4D Molecular Therapeutics Inc

Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-2.80
vs median 35.63
P/B
1.00
vs median 2.25
ROE
-0.37
vs median 0.09

Lower quality - review fundamentals carefully

Small-cap company with higher volatility

Similar companies

NGNEIMMXIMRAPRTACTNMALLO
Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics